108 related articles for article (PubMed ID: 11069235)
1. Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tat-mediated pathogenesis.
Benelli R; Barbero A; Ferrini S; Scapini P; Cassatella M; Bussolino F; Tacchetti C; Noonan DM; Albini A
J Infect Dis; 2000 Dec; 182(6):1643-51. PubMed ID: 11069235
[TBL] [Abstract][Full Text] [Related]
2. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis.
Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725
[TBL] [Abstract][Full Text] [Related]
3. Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis.
Benelli R; Morini M; Brigati C; Noonan DM; Albini A
Int J Oncol; 2003 Jan; 22(1):87-91. PubMed ID: 12469189
[TBL] [Abstract][Full Text] [Related]
4. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
[TBL] [Abstract][Full Text] [Related]
5. Identification of HIV-1 Tat peptides for future therapeutic angiogenesis.
Ismail M; Henklein P; Huang X; Braumann C; Rückert RI; Dubiel W
Eur J Haematol; 2006 Aug; 77(2):157-65. PubMed ID: 16800839
[TBL] [Abstract][Full Text] [Related]
6. Rho family GTPases regulate VEGF-stimulated endothelial cell motility.
Soga N; Namba N; McAllister S; Cornelius L; Teitelbaum SL; Dowdy SF; Kawamura J; Hruska KA
Exp Cell Res; 2001 Sep; 269(1):73-87. PubMed ID: 11525641
[TBL] [Abstract][Full Text] [Related]
7. HIV-tat protein is a heparin-binding angiogenic growth factor.
Albini A; Benelli R; Presta M; Rusnati M; Ziche M; Rubartelli A; Paglialunga G; Bussolino F; Noonan D
Oncogene; 1996 Jan; 12(2):289-97. PubMed ID: 8570206
[TBL] [Abstract][Full Text] [Related]
8. Decorin suppresses tumor cell-mediated angiogenesis.
Grant DS; Yenisey C; Rose RW; Tootell M; Santra M; Iozzo RV
Oncogene; 2002 Jul; 21(31):4765-77. PubMed ID: 12101415
[TBL] [Abstract][Full Text] [Related]
9. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
[TBL] [Abstract][Full Text] [Related]
10. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.
Albini A; Soldi R; Giunciuglio D; Giraudo E; Benelli R; Primo L; Noonan D; Salio M; Camussi G; Rockl W; Bussolino F
Nat Med; 1996 Dec; 2(12):1371-5. PubMed ID: 8946838
[TBL] [Abstract][Full Text] [Related]
11. Growth factor regulation of neutrophil-endothelial cell interactions.
Zhang H; Issekutz AC
J Leukoc Biol; 2001 Aug; 70(2):225-32. PubMed ID: 11493614
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC
J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550
[TBL] [Abstract][Full Text] [Related]
13. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
Niu G; Wright KL; Huang M; Song L; Haura E; Turkson J; Zhang S; Wang T; Sinibaldi D; Coppola D; Heller R; Ellis LM; Karras J; Bromberg J; Pardoll D; Jove R; Yu H
Oncogene; 2002 Mar; 21(13):2000-8. PubMed ID: 11960372
[TBL] [Abstract][Full Text] [Related]
14. HIV TAT basic peptide is not a high-affinity ligand for VEGF receptor 2.
Rubio Demirovic A; Canadi J; Weiglhofer W; Scheidegger P; Jaussi R; Kurt BH
Biol Chem; 2003; 384(10-11):1435-41. PubMed ID: 14669986
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells.
Lee YW; Eum SY; Nath A; Toborek M
Cardiovasc Res; 2004 Jul; 63(1):139-48. PubMed ID: 15194470
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
Masso-Welch PA; Zangani D; Ip C; Vaughan MM; Shoemaker S; Ramirez RA; Ip MM
Cancer Res; 2002 Aug; 62(15):4383-9. PubMed ID: 12154044
[TBL] [Abstract][Full Text] [Related]
17. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
18. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
19. Evidence of human thrombomodulin domain as a novel angiogenic factor.
Shi CS; Shi GY; Chang YS; Han HS; Kuo CH; Liu C; Huang HC; Chang YJ; Chen PS; Wu HL
Circulation; 2005 Apr; 111(13):1627-36. PubMed ID: 15795324
[TBL] [Abstract][Full Text] [Related]
20. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).
Chen WS; Kitson RP; Goldfarb RH
In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
